Chemoinformaics analysis of Isosecotanapartholide
| Molecular Weight | 278.304 | nRot | 4 |
| Heavy Atom Molecular Weight | 260.16 | nRig | 15 |
| Exact Molecular Weight | 278.115 | nRing | 2 |
| Solubility: LogS | -1.846 | nHRing | 1 |
| Solubility: LogP | 0.558 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 38 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 20 | No. of Aromatic Carbocycles | 0 |
| nHetero | 5 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 5 | No. of Arom Bond | 0 |
| nHA | 5 | APOL | 41.0623 |
| nHD | 1 | BPOL | 22.3977 |
| QED | 0.439 |
| Synth | 4.346 |
| Natural Product Likeliness | 2.18 |
| NR-PPAR-gamma | 0.715 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.002 |
| HIA | 0.137 |
| CACO-2 | -4.638 |
| MDCK | 0.0000463 |
| BBB | 0.236 |
| PPB | 0.519137 |
| VDSS | 0.373 |
| FU | 0.585139 |
| CYP1A2-inh | 0.045 |
| CYP1A2-sub | 0.405 |
| CYP2c19-inh | 0.034 |
| CYP2c19-sub | 0.201 |
| CYP2c9-inh | 0.059 |
| CYP2c9-sub | 0.179 |
| CYP2d6-inh | 0.013 |
| CYP2d6-sub | 0.275 |
| CYP3a4-inh | 0.052 |
| CYP3a4-sub | 0.266 |
| CL | 11.773 |
| T12 | 0.869 |
| hERG | 0.008 |
| Ames | 0.01 |
| ROA | 0.855 |
| SkinSen | 0.58 |
| Carcinogencity | 0.15 |
| EI | 0.178 |
| Respiratory | 0.808 |
| NR-Aromatase | 0.008 |
| Antiviral | Yes |
| Prediction | 0.814307 |